Characterizing a cohort of Egyptian patients with acute-on-chronic liver failure

Bibliographic Information
Authors: El Ray A.; Fouad R.; Elmakhzangy H.; El Beshlawy M.; Moreau R.; Sherbiny M.
Journal: European Journal of Gastroenterology and Hepatology
Publisher: Lippincott Williams and Wilkins
Publication Date: 19 April 2021
Volume / Issue: Volume 33 / Issue 7
Pages: 1023–1028
ISSN: 0954691X
DOI: 10.1097/MEG.0000000000002165
Scopus: View on Scopus
PubMed: 33905215
Document Type: Article
Authors and Affiliations
El Ray A., Hepatogastroenterology Department, Theodor Bilharz Research Institute, El Nile St. Warak Elhadar P.Box 30, Giza, 12411, Egypt; Fouad R., Endemic Medicine and Hepatogastroenterolgy Department, Faculty of Medicine, Cairo University, Egypt; Elmakhzangy H., Endemic Medicine and Hepatogastroenterolgy Department, Faculty of Medicine, Cairo University, Egypt; El Beshlawy M., Endemic Medicine and Hepatogastroenterolgy Department, Faculty of Medicine, Cairo University, Egypt; Moreau R., EF Clif, EASL-CLIF Consortium and Grifols Chair, Barcelona, Spain, Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Paris, Centre de Recherche sur l'Inflammation (CRI), Paris, France, Assistance Publique - Hôpitaux de Paris (APHP), Service d'Hépatologie & Réanimation HépatoDigestive, Hôpital Beaujon, Clichy, France; Sherbiny M., Hepatogastroenterology Department, Theodor Bilharz Research Institute, El Nile St. Warak Elhadar P.Box 30, Giza, 12411, Egypt
Abstract
Background and Aim Several studies performed in Western countries and Asia have shown that acute-on-chronic liver failure (ACLF) is an acute decompensation of cirrhosis characterized by organ system failures and high short-term mortality. However, the characteristics of Egyptian patients with ACLF have not yet been described. The aim of this study was to assess Egyptian patients with cirrhosis hospitalized for an acute decompensation using criteria and scores developed by the EASL-CLIF Consortium. Patients and methods One hundred and twenty patients with acutely decompensated cirrhosis nonelectively admitted to two tertiary hospitals were prospectively included. Ninety-three percent of patients had hepatitis C virus-related liver disease. Results Of the 120 patients, 40 had ACLF; of these 45% had ACLF-1, 33% ACLF-2, and the remaining 22% had ACLF-3. None of the patients with ACLF had received direct-antiviral agents (DAAs) while 30% of patients without ACLF were treated with these agents. The prevalence of prior episodes of decompensation was significantly higher in patients with ACLF (60% vs. 28%). The prevalence of precipitating events such as bacterial infection alone or combined with gastrointestinal hemorrhage was higher in patients with ACLF than in those without. Systemic inflammation, assessed with white blood-cell count and plasma C reactive levels, was more intense in ACLF. Conclusion Among Egyptian patients with acutely decompensated cirrhosis nonelectively admitted to the hospital, those with ACLF were distinct from those without ACLF, not only by the presence of organ failures, but also the absence DAA therapy, more frequent prior episodes of decompensation, more frequent bacterial infections as a precipitant, and more intense systemic inflammation. © 2021 Lippincott Williams and Wilkins. All rights reserved.
Keywords
acute-on-chronic liver failure; Egyptian patients; hepatitis C virus; Antiviral Agents; Egypt; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Prognosis; alanine aminotransferase; albumin; antivirus agent; aspartate aminotransferase; bilirubin; creatinine; hypertensive factor; prothrombin; sodium ion; acute on chronic liver failure; adult; Article; bacterial infection; brain dysfunction; clinical assessment; cohort analysis; decompensated liver cirrhosis; Egyptian; female; gastrointestinal hemorrhage; hepatic encephalopathy; hospital admission; hospitalization; human; human tissue; ischemia; kidney failure; leukocyte count; liver failure; lung insufficiency; major clinical study; male; multicenter study; prevalence; prospective study; solitary kidney; tertiary care center; chronic hepatitis C; complication
Citation Information
Scopus Citations: 3
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
